Fibroblast Growth Factor 19 Induced Changes in Non-malignant Cholangiocytes.
Jiaqi YangDavid SontagSam KungGerald Y MinukPublished in: Journal of clinical and translational hepatology (2021)
Six weeks of FGF19 exposure did not result in the acquisition of permanent malignant features in non-malignant, human cholangiocytes.